243
Participants
Start Date
June 30, 2010
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
Placebo capsule
3x Placebo capsules three times a day (TID) for 365 days
EPA-E 300 mg capsule
2x 300 mg capsules + placebo capsule TID for 365 days
EPA-E 300 mg capsule
3x 300 mg capsules TID for 365 days
Mochida Investigative Site, Plainview
Mochida Investigative Site, Chevy Chase
Mochida Investigative Site, Richmond
Mochida Investigative Site, Newport News
Mochida Investigative Site, Durham
Mochida Investigative Site, Asheville
Mochida Investigative Site, Hialeah
Mochida Investigative Site, Dothan
Mochida Investigative Site, Nashville
Mochida Investigative Site (2 sites), Germantown
Mochida Investigative Site, Tupelo
Mochida Investigative Site, Jackson
Mochida Investigative Site, Lexington
Mochida Investigative Site, Cleveland
Mochida Investigative Site, Cincinnati
Mochida Investigative Site, Cincinnati
Mochida Investigative Site, Detroit
Mochida Investigative Site, Plymouth
Mochida Investigative Site, Chicago
Mochida Investigative Site, New Orleans
Mochida Investigative Site, Houston
Mochida Investigative Site (2 sites), Houston
Mochida Investigative Site, San Antonio
Mochida Investigative Site, Littleton
Mochida Investigative Site, Tucson
Mochida Investigative Site, Los Angeles
Mochida Investigative Site, La Jolla
Mochida Investigative Site, Coronado
Mochida Investigative Site, San Diego
Mochida Investigative Site, San Diego
Mochida Investigative Site, Anaheim
Mochida Investigative Site, Seattle
Mochida Investigative Site, Providence
Mochida Investigative Site, San Juan
Lead Sponsor
Mochida Pharmaceutical Company, Ltd.
INDUSTRY